F · Healthcare

MARINOMED BIOTECH AG INH. (93Z)

Biotechnology

MARINOMED BIOTECH AG INH. (93Z) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 93Z

P/E ratio

18.00

MARINOMED BIOTECH AG INH. (93Z) — FAQ

What is 93Z's P/E ratio?

The price-to-earnings (P/E) ratio for MARINOMED BIOTECH AG INH. (93Z) is 18.00 (data as of 2026-03-25).

Does MARINOMED BIOTECH AG INH. pay a dividend?

Dividend yield is not available in the current snapshot for MARINOMED BIOTECH AG INH. (93Z). Check the MyAverix Finance app for the latest dividend data.

What sector is MARINOMED BIOTECH AG INH. in?

MARINOMED BIOTECH AG INH. (93Z) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 93Z listed on?

93Z is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)